Medicare’s Drug Price Controls Could Actually Raise Prices In The Long Run

Lawmakers promised that letting Medicare set drug prices would save taxpayers more than $100 billion over a decade. New research suggests the IRA may accomplish the opposite in the long run.

Visit the original source for the full article